Try our Advanced Search for more refined results
January 31, 2020
Pfizer Inc. et al v. Viwit Pharmaceutical Co., Ltd.
Case Number:
1:20-cv-00160
Court:
Nature of Suit:
Patent - Abbreviated New Drug Application(ANDA)
Judge:
Firms
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
February 03, 2020
Pfizer Fights Chinese Drugmaker Over Chantix Generic
Pharmaceutical giant Pfizer and company subsidiaries have accused China-based competitor Viwit Pharmaceuticals of violating patents for anti-smoking drug Chantix in the pursuit of selling a generic, according to a complaint filed in Delaware federal court.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login